ARTICLE | Clinical News
Beleodaq belinostat: Phase I data
December 14, 2015 8:00 AM UTC
The open-label, dose-escalation, U.S. Phase I BelCHOP trial in 18 evaluable patients with PTCL showed that IV belinostat plus CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine and predniso...